CANDELA CORP /DE/
10-Q, EX-27.1, 2000-11-14
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: CANDELA CORP /DE/, 10-Q, 2000-11-14
Next: PRINTONTHENET COM INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from SEC Form 10Q and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001             JUL-01-2000
<PERIOD-END>                               SEP-30-2000             OCT-02-1999
<CASH>                                          36,535                  29,538
<SECURITIES>                                         0                       0
<RECEIVABLES>                                   15,280                  13,796
<ALLOWANCES>                                     1,353                   1,205
<INVENTORY>                                      9,939                   6,639
<CURRENT-ASSETS>                                63,054                  52,238
<PP&E>                                           8,274                   7,776
<DEPRECIATION>                                   5,946                   5,256
<TOTAL-ASSETS>                                  70,263                  56,932
<CURRENT-LIABILITIES>                           18,576                  16,389
<BONDS>                                              0                       0
                              115                     109
                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                      48,513                  37,354
<TOTAL-LIABILITY-AND-EQUITY>                    70,263                  56,932
<SALES>                                         16,439                  16,040
<TOTAL-REVENUES>                                13,111                  16,259
<CGS>                                            6,487                   9,141
<TOTAL-COSTS>                                    6,487                   9,141
<OTHER-EXPENSES>                                 6,450                   5,982
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 107                     233
<INCOME-PRETAX>                                    281                   3,392
<INCOME-TAX>                                       112                     678
<INCOME-CONTINUING>                                169                   2,714
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                       169                   2,714
<EPS-BASIC>                                       0.02                    0.26
<EPS-DILUTED>                                     0.01                    0.23


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission